Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with ...
Q2 2026
Aug 4, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 10, 2026
Q4 2025
Q3 2025
Nov 4, 2025